Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
  • C12M1/00—Apparatus for enzymology or microbiology
  • C12M1/24—Apparatus for enzymology or microbiology tube or bottle type
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
  • C12N15/09—Recombinant DNA-technology
  • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
  • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
  • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
  • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
  • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
  • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
  • B01L3/5021—Test tubes specially adapted for centrifugation purposes
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
  • C12M1/00—Apparatus for enzymology or microbiology
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
  • B01L2200/06—Fluid handling related problems
  • B01L2200/0631—Purification arrangements, e.g. solid phase extraction [SPE]
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2300/00—Additional constructional details
  • B01L2300/06—Auxiliary integrated devices, integrated components
  • B01L2300/0681—Filter
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2300/00—Additional constructional details
  • B01L2300/06—Auxiliary integrated devices, integrated components
  • B01L2300/069—Absorbents; Gels to retain a fluid
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2300/00—Additional constructional details
  • B01L2300/08—Geometry, shape and general structure
  • B01L2300/0832—Geometry, shape and general structure cylindrical, tube shaped

Definitions

• the present invention relates to a nucleic acid extracting apparatus, and more particularly, it relates to a nucleic acid extracting apparatus that uses a hydrogel column as a supporting member.
• nucleic acid contaminating material dissolves nucleic acid to be tested and causes an error in measurement of nucleic acid quantity.
• a contaminating material includes a low-molecular material such as fat, an enzyme inhibitor, an enzyme such as a protein, a polysaccharide, and a polynucleotide.
• a method for extracting nucleic acid from a cell includes a method in which a specimen including the cell is solubilized by being processed with sodium dodecyl sulfate (SDS) or proteinase K and then protein is denaturalized and eliminated with penyol so as to refine the nucleic acid.
• SDS sodium dodecyl sulfate
• penyol penyol
• a kit using a column has become a basic tool for nucleic acid extraction in order to reduce the above-stated problems.
• This tool uses a method with silica or fiberglass that uniquely combines with nucleic acid, and the method dissolves a cell by processing it with a chaotropic reagent and refines nucleic acid molecules from protein and other materials in the cell by using a structural interactive mechanism between a water molecule and nucleic acid.
• the fiberglass or silica film has a low-combination ratio with a cell metabolic material, and therefore relatively highly-concentrated nucleic acid can be obtained.
• this method is more simple compared to the phenol extraction method, this method has drawbacks in complexity of operation and time consumption because the chaotropic reagent or ethanol that strongly blocks an enzyme reaction such as PCR should be completely eliminated.
• the present invention has been made in an effort to provide an extracting apparatus that can more stably and easily extract nucleic acid.
• a nucleic acid extracting apparatus may include a pipe-shaped tube having an open outlet at one end thereof, and a hydrogel supporting member that is provided inside the tube and filters impurities excluding an extraction target material.
• the nucleic acid extracting apparatus may further include a housing in which the tube is inserted and connected with the outlet, and having one side formed in a closed pipe shape.
• the hydrogel supporting member may be formed of an agarose gel, and the agarose gel may include 1% to 2% agarose. Further, the agarose gel may include 0.5% to 5% agarose.
• An injection groove extending in the length direction of the tube may be formed on an upper surface of the hydrogel supporting member, and the injection groove may be formed in a center portion of the hydrogel supporting member.
• a plurality of pressure reducing holes that contact the hydrogel supporting member may be formed at an external circumference of the tube.
• the hydrogel supporting member may be adhered to an inner surface of the tube, and the hydrogel supporting member may be formed in a rotating body shape.
• the nucleic acid extracting apparatus extracts nucleic acid from a cell
• the cell may be a biological sample that may be one selected from a group of an animal sample, a plant sample, or a microscopic organism sample, or may be a human-derived cell that includes blood, blood serum, blood plasma, bone marrow, urine, feces, sputum, cell aspirate, tissue, and a tissue-derived material.
• the nucleic acid extracting apparatus may be provided in a centrifugal separator, and the nucleic acid may be DNA.
• the nucleic acid extracting apparatus may be applied to nucleic acid extraction in a DNA chip test, and may be applied to nucleic acid extraction in point-of-care testing. [Advantageous Effects]
• nucleic acid can be easily extracted without impurities by using a hydrogel supporting member as a filter.
• pure nucleic acid can be obtained by using agarose gel as the hydrogel supporting member.
• Nucleic acid recovery efficiency can be improved by forming an injection groove in the hydrogel supporting member.
• nucleic acid can be more easily extracted while reducing damage to the nucleic acid by forming a pressure-reducing hole in a tube.
• FIG. 1 is a cross-sectional view of a nucleic acid extracting apparatus according to a first exemplary embodiment of the present invention.
• FIG. 2 is an electrophoresis photo of a genomic DNA of MC3T3 osteoblast separated by using the nucleic acid extracting apparatus according to the present invention.
• FIG. 3 is a photo of a polymerase chain reaction result for checking purity of the genomic DNA of the MC3T3 osteoblast separated by using the nucleic acid extracting apparatus according to the present invention.
• FIG. 4 is a photo of an electrophoresis result after PCR of nucleic acid of an HPV cell extracted by using the nucleic acid extracting apparatus according to the first exemplary embodiment of the present invention.
• FIG. 5 is a photo of a nucleic acid chip test result of nucleic acid of the HPV cell extracted by using the nucleic acid extracting apparatus according to the first exemplary embodiment of the present invention.
• FIG. 6 is a cross-sectional view of a nucleic acid extracting apparatus according to a second exemplary embodiment of the present invention.
• FIG. 7 is a cross-sectional view of a nucleic acid extracting apparatus according to a third exemplary embodiment of the present invention.
• FIG. 1 is a cross-sectional view of a nucleic acid extracting apparatus according to a first exemplary embodiment of the present invention.
• a nucleic acid extracting apparatus includes a housing 12 that forms an external shape of the nucleic acid extracting apparatus, a tube 14 that is inserted into the housing 12, a hydrogel supporting member 16 installed inside the tube 14, and a cover 13 that covers the tube 14.
• the housing 12 is formed of a cylindrical pipe having a space therein, and a lower portion thereof is closed. In addition, the interior diameter of the housing 12 is gradually decreased toward the bottom thereof so that extracted nucleic acid or acid can be collected therein.
• the tube 14 is inserted inside the housing, and a space is formed therein for containing a cell extract.
• An outlet 24 that is open bottomward is formed in a lower portion of the tube 14 so that nucleic acid can move to the housing therethrough.
• the interior diameter of the outlet 24 is smaller than other portions thereof for passing only nucleic acid excluding proteins and the like therethrough.
• the hydrogel supporting member 16 is provided in the tube 14, and has a shape that corresponds to the internal shape of the tube 14.
• the shape is approximately columnar, has a rotating body.
• the hydrogel supporting member 16 in the present exemplary embodiment is formed of agarose gel that can be easily formed and is harmless to the human body.
• the present exemplary embodiment is not limited thereof, and various hydrogels can be applied.
• the hydrogel supporting member 16 includes agarose in a concentration of 1.0% to 2.0%, and the volume thereof may be 300 ⁇ Jt to 600/zt
• the hydrogel column 16 can be easily broken during the centrifugal separation process, and when the concentration of the agarose is higher than 2.0%, an aperture becomes too small to sufficiently extract the nucleic acid.
• the hydrogel column 16 can include agarose at 0.5% to 5.0%.
• the hydrogel column 16 includes the agarose at less than 5.0% in order to prevent the hydrogel column 16 from being easily broken.
• the agarose is included at more than 5.0%, the pore size thereof is reduced so that the nucleic acid cannot pass through the hydrogel column 16.
• the hydrogel column 16 includes less than 0.5% agarose, the size of the pores becomes too large, and the hydrogel column 16 may by broken due to pressure or a foreign material may be separated through the agarose gel column.
• the hydrogel is a polymer material that can contains moisture, and has a three-dimensional network structure in which molecules are connected to each other by chemical and physical combinations.
• the hydrogel contains moisture by a hydrophilic functional group, capillary action, and osmotic pressure. Accordingly, the hydrogel has superior air permeability and percolate absorption, and is friendly to blood, body fluids, and body tissue.
• the hydrogel supporting member 16 is hydrophilic and has the three- dimensional network structure, and therefore it can function as a nucleic acid filter during the centrifugal separation process. That is, since the nucleic acid included in the cell extract is small in size and is hydrophilic, it may pass through the pores formed in the hydrogel supporting member 16 and be emitted through the outlet 24. However, a relatively large and non-aqueous phase liquid impurity such as a protein cannot pass through the hydrogel supporting member 16 so that it remains in the tube 14.
• the cell extract refers to a mixture that includes cell components obtained by destroying the cell.
• the cell may be formed of a biological sample of an animal, a plant, or a microscopic organism.
• the cell may be a human-derived cell that includes blood, blood serum, blood plasma, bone marrow, urine, feces, sputum, cell aspirate, tissue, and a tissue-derived material.
• the cell extract can be made by adding a lysis buffer into a container in which a cell is contained, and the lysis buffer may be formed of various commercially available materials.
• a proteinase K which is a protein hydrolase or an RNase which is a ribo DNAase may be further included in addition to the lysis buffer,.
• the hydrogel supporting member 16 is formed in the tube 14.
• the hydrogel supporting member 16 is formed of an agarose gel including 2% agarose.
• the concentration of the agarose may be variously changed in accordance with viscosity or concentration of the sample.
• the agarose After adding the agarose to distilled water, the agarose is dissolved by heating the mixture. Then, the agarose aqueous solution is added into the tube 14 and then the tube 14 is left at room temperature so as to form the column-shaped hydrogel supporting member 16.
• the cell extract is inserted into the tube 14 where the hydrogel supporting member 16 is formed and then a centrifugal separating process is performed.
• the centrifugal separating process is performed three times, each time taking 5 minutes, at 2000rpm in a micro-centrifugal separator.
• DNA passes through the hydrogel supporting member 16 and is emitted to the housing 12 through the outlet 24, and foreign materials such as proteins that cannot pass through the hydrogel remain behind.
• the nucleic acid is extracted by using the centrifugal separator, but the present invention is not limited thereto. Therefore, the nucleic acid can be extracted by using pressure or an electrical method, and in this case, the hydrogel supporting member 16 is used as a filter.
• the extracted nucleic acid may be used in a genome test or a DNA chip test. That is, the nucleic acid extracting apparatus according to the present exemplary embodiment can be applied to nucleic acid extraction in a genome test or a DNA chip test.
• the nucleic acid extracting apparatus may be applied in nucleic acid extraction in a point-of-care test (generally referred to as POC test).
• POC test is a test that can be performed to diagnose a disease of a patient at a clinic or hospital setting or at the home of a patient.
• the nucleic acid extracting apparatus according to the present exemplary embodiment can be portably used since it can extract nucleic acid with a simple structure, and therefore nucleic acid extracted by the portably extracting apparatus can be easily applied to the POC test.
• FIG. 2 shows an electrophoresis result of DNA collected by using the housing 12.
• FIG. 2 is an electrophoresis photo of genomic DNA of an MC3T3 osteoblast separated by using the nucleic acid extracting apparatus according to the present invention.
• lane M is a standard DNA marker
• lane M is a standard DNA marker
• 1 and lane 2 are electrophoresis results of the genomic DNA of the MC 3T3 osteoblast obtained by using a method according to the present invention.
• FIG. 3 is a photo of a polymerase chain reaction result for checking purity of the genomic DNA of the MC3T3 osteoblast separated by using the nucleic acid extracting apparatus according to the present invention
• lane M is a standard DNA marker
• lane 1 is an electrophoresis result after amplifying glyceraldehyde-3-phosphate dehydrogenase (G3PHD) in the genomic DNA of the MC3T3 osteoblast obtained by using the method according to the present invention.
• Lanes 2 and 3 are glyceraldehyde-3-phosphate dehydrogenase (G3PHD) in the genomic DNA of the MC3T3 osteoblast obtained by using the method according to the present invention.
• MC3T3 osteoblast obtained by using a commercially available genomic DNA extracting apparatus.
• DNA is applied as the nucleic acid, but the present invention is not limited thereto. That is, the present exemplary embodiment can be applied to nucleic acid separation of various kinds, such as RNA.
• a test that included a hybridization process was selected from among tests using DNA.
• HPV DNA chip test was performed on a result of the DNA extraction.
• an electrophoresis reading was performed after a general PCR test.
• the specimen was HPV-58, and Proteinase K at 2Q ⁇ Ji, a specimen for HPV test at 400/ ⁇ 6, and a lysis buffer at 200/ ⁇ were added into a tube where the agarose gel supporting member was present, and then centrifugal separation was performed three times for 5 minutes each time at 2000RPM/200RCF.
• a supporting member having a volume of 0.3m£ and a supporting member having a volume of 0.6m£ were used as the agarose supporting member.
• FIG. 4 is a photo showing an electrophoresis result after a PCR test was performed
• FIG. 5 is a photo of a DNA chip test result.
• FIG. 4 and FIG. 5 when a result of a general PCR test is read with electrophoresis, the result could be read only when both of the 0.3 mi and 0.6 mi columns are in an agarose gel of 2%. Meanwhile, in the DNA chip test in which a result can be obtained even though the number of DNA copies is low, an accurate HPV type result could be obtained in agarose gel of 1%, 1.5%, and 2% in the 0.3m£ supporting member and in agarose gel of 2% in the 0.6ml supporting member.
• the general PCR test and the DNA chip test for obtaining HPV type information could be performed on both the 0.3m-& and 0.6m£ supporting members when agarose gel of 2% was used.
• An experiment was performed to compare the nucleic acid extracting apparatus according to the present exemplary embodiment with a nucleic acid extracting method that has been commonly used so as to evaluate the nucleic acid extraction efficiency of the nucleic acid extracting apparatus of the present exemplary embodiment.
• nucleic acid was extracted by using a commonly used nucleic acid extracting apparatus and the nucleic acid extracting apparatus according to the present exemplary embodiment, and then a recovery ratios of each method were compared by measuring concentrations of the extracted nucleic acid.
• HPV-18 HPV-18 was used as a specimen, and proteinase K at 20 ⁇ £, DNA extraction specimen at 200 ⁇ £, and lysis buffer at 200M were added to the specimen, and centrifugal separation was performed on the mixture at 2000RPM/200RCF for 15 minutes.
• the agarose gel at a concentration of 2.0% and the hydrogel supporting members respectively having 0.3m£ and 0.6ml volumes were used.
• DNA-acid concentration of 65#gM of DNA extract used in the test the commonly-used nucleic acid extracting method provides ⁇ A ⁇ g/ml, that is, approximately a 21.5% recovery rate, and 2% agarose gel 0.3 ml and 0.6 ml respectively provided
• the result of the comparison demonstrates that the efficiency of the nucleic acid extracting apparatus of the present exemplary embodiment is included within a range for clinical application.
• the nucleic acid extracting apparatus of the present exemplary embodiment is particularly advantageous to extract DNA of a biological specimen.
• FIG. 6 is a cross-sectional view of a nucleic acid extracting apparatus according to a second exemplary embodiment of the present invention.
• a nucleic acid extracting apparatus includes a cylindrical housing 12, a tube 14 inserted inside the housing 12, a hydrogel supporting member 17 provided in the tube 14, and a cover 19 that covers the tube 14.
• An injection groove 18 is formed inside the hydrogel supporting member 17 according to the present exemplary embodiment.
• the injection groove 18 is formed in a center portion of the hydrogel supporting member 17, and may be formed in a cylindrical shape.
• Such an injection groove 18 can contain cell extract, and reduces a distance between an outlet 24 and the cell extract, thereby improving nucleic acid recovery efficiency.
• a plurality of micropores are formed in the hydrogel supporting member 17, and nucleic acid is emitted to the outlet 24 through the plurality of micropores during the centrifugal separation process. Accordingly, when the distance between the cell extract and the outlet 24 is decreased, the nucleic acid can more easily pass through the hydrogel supporting member 17 so that the nucleic acid recovery efficiency can be improved.
• FIG. 7 is a cross-sectional view of a nucleic acid extracting apparatus according to a third exemplary embodiment of the present invention.
• a nucleic acid extracting apparatus according to the present exemplary embodiment includes a cylindrical housing 12, a tube 14 inserted into the housing 12, a hydrogel supporting member 17 installed inside the tube 14, and a cover 19 that covers the tube 14.
• a plurality of pressure reducing holes 15 are formed at an external circumference of the tube 14 where the hydrogel supporting member 17 is disposed, and the pressure holes 15 reduce pressure generated due to the centrifugal force.
• an injection groove 18 is formed in the hydrogel supporting member 17, and the pressure reducing holes 15 are formed at a side of the injection groove 18. Accordingly, nucleic acid in the injection groove 18 can be emitted to the housing 12 through the pressure reducing grooves 15 so that the nucleic acid recovery efficiency can be further improved.

Landscapes

• Chemical & Material Sciences (AREA)
• Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Life Sciences & Earth Sciences (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Biomedical Technology (AREA)
• Genetics & Genomics (AREA)
• Zoology (AREA)
• Biotechnology (AREA)
• Wood Science & Technology (AREA)
• General Health & Medical Sciences (AREA)
• Organic Chemistry (AREA)
• General Engineering & Computer Science (AREA)
• Analytical Chemistry (AREA)
• Hematology (AREA)
• Biochemistry (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Clinical Laboratory Science (AREA)
• Microbiology (AREA)
• Plant Pathology (AREA)
• Biophysics (AREA)
• Molecular Biology (AREA)
• Physics & Mathematics (AREA)
• Crystallography & Structural Chemistry (AREA)
• Medicinal Chemistry (AREA)
• Sustainable Development (AREA)
• Apparatus Associated With Microorganisms And Enzymes (AREA)
• Treatment Of Liquids With Adsorbents In General (AREA)
• Solid-Sorbent Or Filter-Aiding Compositions (AREA)
• Centrifugal Separators (AREA)
• Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Priority Applications (4)

Applications Claiming Priority (2)

Publications (1)

Family

ID=41444697

Family Applications (1)

Country Status (6)

Cited By (4)

Families Citing this family (22)

Citations (4)

Family Cites Families (8)

• 2008
  • 2008-06-27 KR KR1020080061902A patent/KR101005924B1/ko not_active IP Right Cessation
• 2009
  • 2009-06-22 US US13/001,441 patent/US8815572B2/en active Active
  • 2009-06-22 JP JP2011516118A patent/JP5202732B2/ja not_active Expired - Fee Related
  • 2009-06-22 WO PCT/KR2009/003340 patent/WO2009157679A1/en active Application Filing
  • 2009-06-22 EP EP09770351.6A patent/EP2303458B1/en active Active
  • 2009-06-22 CN CN200980134053.XA patent/CN102137719B/zh active Active

Patent Citations (4)

Non-Patent Citations (6)

Also Published As

Similar Documents

Legal Events